Frontier AI companies are expanding healthcare products and in-house drug research as public opposition to energy-hungry data centers and distrust of the labs themselves have intensified — a bet that real medical progress would repair an image now tied to higher utility bills and environmental strain.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.